AQP5 Polymorphism
AssigneeUniversitäT Duisburg-Essen
InventorsMichael Adamzik, Ulrich Frey, Winfried Siffert
Life of this patent
Estimating the term…
Abstract
In order to predict disease risks, disease courses and the response of an individual patient to pharmacological and non-pharmacological therapies a polymorphism in the AQP5 gene has been investigated, in particular in the promoter region of said gene,on the human 12q13 chromosome, wherein the therapy can also be a cosmetic treatment.
Claims5
An in-vitro method for predicting disease risks, disease courses and the response of an individual patient to pharmacological and nonpharmacological treatments, said method comprising screening for a polymorphism in the AQP5 gene on the human chromosome 12q13.
5-8. (canceled)
Dependencies are inferred from the claim text.